Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2019-05-15 | 2019-05-25 | 84108 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2019-05-15 | 2019-06-01 | 84112 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2019-08-07 | 2019-09-23 | 91067 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2017-03-10 | 2017-07-20 | 61 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2017-03-10 | 2017-07-20 | 64 |
| APO-ATOMOXETINE | 18MG | CAPSULE | Resolved | 2017-03-17 | 2017-07-17 | 3160 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-06-02 | 2023-07-07 | 193600 |
| APO-ATOMOXETINE | 100MG | CAPSULE | Resolved | 2024-05-24 | 2024-10-11 | 228792 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-05-30 | 2024-10-04 | 229164 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2024-05-30 | 2024-10-04 | 229167 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2024-07-12 | 2024-09-27 | 232818 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2024-08-01 | 2024-10-04 | 234317 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-09-05 | 2024-10-04 | 236872 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-11-07 | 2024-12-20 | 242211 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-10 | 2024-05-24 | 227725 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-05-31 | 2024-06-07 | 229401 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-09-05 | 2024-11-01 | 236875 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-12-12 | 2025-01-03 | 245505 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-11-17 | 2023-12-01 | 210695 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-11-24 | 2023-12-01 | 211493 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |